BRVOBranch Retinal Venous Occlusion
Copyright 1988-2018, All rights reserved.
References in periodicals archive ?
Sex Distribution: In this study we found a slight male preponderance for both CRVO and BRVO with approximately 54% incidence respectively.
In our study branch retinal vein occlusion (BRVO) was the most common ocular manifestation (20.4%) of hHcy.
An additional exclusion criterion for patients with branch RVO (BRVO) was duration of BRVO < 3 months.
Problems with attempted chorioretinal venous anastomosis by laser for nonischemic CRVO and BRVO. Ophthalmologica.
Weeks to months after the onset of BRVO, collateral vessel formation can be observed characteristically located at the edge of the involved area.
During the postoperative course, the following retinal vascular occlusions were identified: BRAO (n = 2), CRAO (n = 2), BRVO (n = 1), CRVO (n = 1), AION (n = 3), and combined central artery and vein occlusion (n = 1).
Branch retinal vein occlusion (BRVO) is considered the second most common retinal vascular disease, the frequency of which is surpassed only by diabetic retinopathy [1-3].
Branch retinal vein occlusion (BRVO) is the second most frequent major retinal vascular disease after diabetic retinopathy [1].
Thus treatment options for managing macular oedema with BRVO include both macular grid laser photo coagulation and intravitreal injections4-8.
Next, we performed the subgroup analyses by the factors of ethnicity (Caucasian), control source (population-based control; hospital-based control), and RVO type (BRVO or CRVO).
6 cases of BRVO on FA showed presence of CMO, HTN retinopathy and NVE in 2 cases each.
Triamcinolone acetonide, a synthetic glucocorticoid is used intravitrealy to treat a variety of ocular diseases such as cystoid macular edema (CME) after cataract surgery11, macular edema due to retinal vascular conditions, such as diabetic retinopathy12, central retinal vein occlusion (CRVO) 13, branch retinal vein occlusion (BRVO)14 and macular edema due to inflammatory conditions e.g.